Gynecologic Cancer
Gynecologic Oncology Consult
Decision making regarding LEEP versus cone biopsy for excision of cervical dysplasia
While both techniques are associated with equivalent efficacy in disease control, each has its virtues and advantages, and clinical judgment is...
Conference Coverage
Cervical cancer rates fall, but other HPV cancers increase
Product Review
FDA and power morcellation, gel for vaginal odor, and an intrauterine electrosurgery system
FDA and power morcellation, gel for vaginal odor, and an intrauterine electrosurgery system
FDA guidance for...
Conference Coverage
For cervical cancer screening, any strategy is acceptable
Plus, an expert explains why increased rates of HPV vaccination may affect future screening guidelines.
Conference Coverage
Success in LGBTQ+ medicine requires awareness of risk
Cross-sex hormone therapy is a life-sustaining treatment that should be viewed analogously with any other long-term management strategy, such as...
Gynecologic Oncology Consult
Surgery for early-stage cervical cancer: Are we still too radical?
Radical vaginal or abdominal trachelectomy is associated with cancer recurrence rates of less than 5% and successful pregnancy in approximately...
News from the FDA/CDC
FDA approves new immunotherapy for endometrial cancer
The accelerated approval for dostarlimab is for use in patients with recurrent or advanced endometrial cancers with deficient mismatch repair.
Expert Commentary
Can a once-daily oral formulation treat symptoms of uterine fibroids without causing hot flashes or bone loss?
Menstrual bleeding was significantly reduced among women with uterine fibroids who took a new once-daily...
Conference Coverage
Endometrial thickness could predict cancer, guide lymph node assessment
Patients with endometrial intraepithelial neoplasia don’t need routine lymph node sampling, an investigator says.
Commentary
How physicians can provide better care to transgender patients
Those transgender patients who seek care often have unpleasant experiences.
Feature
Cancer screening stopped by pandemic: Repercussions to come?